• Manuel Serrano, Spanish National Cancer Research Center, CNIO, Madrid.

• Stuart Orkin, Dana-Farber Cancer Institute. Harvard Medical School, Boston.

• Marteen von Lohuizen, NKI, Amsterdam.

• Michael Schneider, Imperial College London, London

• Susana González López
• Junior group leader
• Ext.2307

Susana Gonzalez obtained her degree in Chemistry and Molecular Biology at the Universidad Autónoma de Madrid in 1994. Susana devoted her thesis work to the study of the molecular mechanisms of influenza virus under the supervision of Dr. Juan Ortin at the Centro Nacional de Biotecnología in Madrid. She received her PhD from the Universidad Autónoma de Madrid.

In 2000, Susana was awarded a postdoctoral fellowship from the Human Frontier Science Program (HFSP) to work in New York with Carlos Cordon-Cardo at the Memorial Sloan-Kettering Cancer Center and Carol Prives at Columbia University. Her work in this period focused on different tumor suppression responses. She subsequently moved to Manuel Serrano’s laboratory at the Spanish National Cancer Research Center (Centro Nacional de Investigaciones Oncológicas, in Madrid), where her work helped identify the mechanisms governing the expression of the INK4/ARF locus and the mechanisms through which miRNAs induce heterochromatinization to silence gene promoters. In 2006 Susana was granted an HFSP Career Development Award. She joined the CNIC in 2007.